Clinical Trials in Maryland

Showing 8481-8500 of 17,687 trials

Feasibility of Telemedicine Medical Abortion

NCT04599725

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Pregnancy

Gynuity Health Projects413 participantsStarted Oct 2020

Denver, Colorado, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +12 more locations

COMPLETEDPhase 317 miles

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

This randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib malate or sorafenib tosylate after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sunitinib malate is more effective than sorafenib tosylate or placebo in treating kidney cancer.

Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7Stage II Renal Cell Cancer AJCC v7+1 more

National Cancer Institute (NCI)1,943 participantsStarted Apr 2006

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +984 more locations

Feasibility of Telemedicine Medical Abortion

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Find Trials by Condition in Maryland

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Safety and Dose Finding Study of Xigris in Hemodialysis Patients

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

Youth Opioid Recovery Support: Improving Care Systems

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Active Limb Orthosis for Home-Use Stroke Hemiparetic Gait Rehabilitation

Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer

Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens)